Oocyte and embryo vitrification freezing carrier and method

By designing U-shaped oblique ports on oocytes and embryo vitrification freezing carriers and attaching water-absorbing materials, automatically absorbing the frozen liquid, the difficulty in controlling the volume of frozen liquid and the operation dependence problems in the existing technology is solved, and efficient embryos are achieved Recovery rates and simplified operating procedures reduce costs and expand the scope of technology application.

CN114027295BActive Publication Date: 2024-11-19GRASSLAND WAGYU INVESTMENT CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202111541870.6
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2021-12-16
Publication Date
2024-11-19
Estimated Expiration
2041-12-16

AI Technical Summary

Technical Problem

Existing oocyte and embryo vitrification cryogenic carriers, such as OPS and Cryotop, have poor survival and deficiency after thawing, and their operation depends on years of training experience, resulting in unstable results.

Method used

A new oocyte and embryo vitrification cryogenic carrier was designed, using one end of the cryogenic tube body as a U-shaped inclined mouth, and water-absorbing materials, such as filter paper, are attached to the inner wall of the U-shaped inclined mouth, to automatically absorb excess frozen liquid , control the final volume of frozen liquid to 0.3~0.8μl to improve the freezing efficiency and resuscitation rate.

Benefits of technology

The embryo resuscitation rate has been significantly improved to more than 99%, and the operating process has been simplified, allowing technicians to apply without training, reducing costs, and providing guarantees for the commercial application of vitrification and freezing technology.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN114027295B_ABST
    Figure CN114027295B_ABST
Patent Text Reader

Abstract

The present invention provides an oocyte and embryo vitrification freezing carrier and method, belonging to the field of animal embryo engineering technology. The oocyte and animal embryo vitrification freezing carrier of the present invention comprises a freezing tube body, one end of which is a U-shaped bevel, and a water-absorbing material is attached to the inner wall of the U-shaped bevel end of the freezing tube body. After the freezing liquid containing oocytes and / or embryos is transferred to the water-absorbing material, the excess freezing liquid can be automatically absorbed, and the final freezing liquid volume is controlled to be about 0.5μl, which greatly improves the freezing efficiency. When the freezing carrier of the present invention is used to vitrify animal oocytes and / or embryos, the recovery rate of embryos can reach more than 99%.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of animal embryo engineering, and in particular relates to an oocyte and embryo vitrification freezing carrier and a method. Background Art

[0002] Vitrification of oocytes and embryos is to place oocytes and embryos on a carrier and put them into a liquid nitrogen environment at minus 196℃ for rapid cooling after a series of dehydration, so that the liquid inside and outside the cells reaches a vitrified state. Freezing of oocytes and embryos is one of the important methods to preserve women's reproductive function and animal genetic resources. Vitrification is to treat oocytes and embryos with a high concentration and extremely viscous cryoprotectant, so that the embryos are rapidly cooled from physiological temperature to -196℃ during the freezing process, and the liquid inside and outside the embryo cells is instantly frozen into a vitrified solid state. Compared with the programmed freezing method, during the freezing process of the vitrification method, the liquid in the embryo cells will not form ice crystals, thereby avoiding the physical and chemical damage of ice crystals to oocytes and embryonic cells, and obtaining a better freezing effect. The recovery rate of vitrified frozen embryos usually reaches more than 95%. If the blastocyst is frozen, the effect is better, and the recovery rate can reach more than 99%, which is significantly higher than the programmed freezing method, and the advantages are also obvious. Therefore, more and more centers have gradually begun to use the vitrification freezing method, which has also become the main method of embryo freezing at this stage. Likewise, vitrification has become the gold standard for cryopreservation of oocytes.

[0003] The existing technology center has disclosed a variety of embryo vitrification carriers, such as open stretched capillary (OPS) and Cryotop. However, the survival rate and conception rate of embryos vitrified using OPS and Cryotop after thawing are not ideal. This is because the size of the final freezing liquid volume will affect the cooling and heating rates of the embryo freezing / thawing process, thereby determining the final freezing effect. For example, the final freezing liquid volume of OPS is 2 to 5μl, and the freezing volume is relatively large. The final freezing liquid volume of Cryotop can be controlled at around 1μl, but the excess liquid needs to be manually aspirated, which requires the operator to have many years of training and work experience to complete this complex step, so the operating effect varies from person to person and is unstable. Summary of the invention

[0004] In view of this, the object of the present invention is to provide an oocyte and embryo vitrification freezing carrier and method, which can control the final freezing liquid volume to 0.3-0.8 μl, thereby greatly improving the freezing efficiency.

[0005] The invention provides an oocyte and embryo vitrification freezing carrier, comprising a freezing tube body, one end of which is a U-shaped bevel, and is characterized in that a water-absorbing material is attached to the inner wall of the U-shaped bevel end of the freezing tube body.

[0006] Preferably, the water-absorbing material comprises filter paper.

[0007] Preferably, the shape of the water-absorbing material includes a rectangle; the length of the water-absorbing material is 18 to 20 mm, and the width of the water-absorbing material is 5 to 6 mm.

[0008] Preferably, the outer edge of the water-absorbing material is flush with the outer edge of the U-shaped bevel.

[0009] Preferably, the bevel angle of the U-shaped bevel is 60°.

[0010] Preferably, the length of the U-shaped bevel is 0.5 to 1 cm

[0011] Preferably, the freezing tube body is prepared by obliquely cutting one end of a semen freezing tube; the specification of the semen freezing tube is 0.25 mL.

[0012] The present invention also provides a method for vitrification of oocytes and / or embryos based on the oocyte and embryo vitrification carrier described in the above scheme, comprising the following steps:

[0013] The cryoprecipitate containing oocytes and / or embryos is transferred to the absorbent material of the oocyte and embryo vitrification carrier described in the above protocol and frozen with liquid nitrogen.

[0014] Preferably, the transfer starts 5 to 10 seconds before the embryos are frozen in the freezing solution.

[0015] The present invention provides an oocyte and embryo vitrification freezing carrier, comprising a freezing tube body, one end of the freezing tube body is a U-shaped bevel, and a water-absorbing material is attached to the inner wall of the U-shaped bevel end of the freezing tube body. After the freezing liquid containing oocytes and / or embryos is transferred to the water-absorbing material, the excess freezing liquid can be automatically absorbed, so that the final freezing liquid volume can be controlled to be about 0.5μl, which greatly improves the freezing efficiency and the recovery rate of frozen embryos. This carrier is named "Paper Straw" or "paper tube". The freezing carrier of the present invention is used to vitrify animal oocytes and / or embryos, and the recovery rate of embryos is above 99%. In addition, the use of the carrier of the present invention to vitrify animal oocytes and / or embryos is simple to operate, and technicians can use it without training, which provides technical guarantee for the commercialization of vitrification freezing technology and greatly expands the wide application of this technology in female fertility preservation and livestock breeding. BRIEF DESCRIPTION OF THE DRAWINGS

[0016] Figure 1 Schematic diagram of the structure of a semen freezing tube, wherein 1 is a semen freezing tube body, 11 is a cotton plug;

[0017] Figure 2 Schematic diagram of bevel cutting of a semen cryotube, wherein 1-semen cryotube body, 11-cotton plug, 3-scalpel, 4-length of U-shaped bevel, 5--U-shaped bevel;

[0018] Figure 3 It is a schematic diagram of the water-absorbing material being inserted into the freezing tube body from the U-shaped oblique opening, wherein 1-semen freezing tube body, 11-cotton plug, 2-water-absorbing material, 5--U-shaped oblique opening;

[0019] Figure 4 The present invention is a schematic diagram of adding freezing solution containing oocytes and / or embryos to the water-absorbing material of the vitrified freezing carrier of oocytes and animal embryos, wherein 1 is a semen freezing tube body, 11 is a cotton plug, 2 is a water-absorbing material, 5 is a U-shaped oblique mouth, and 6 is a freezing solution containing oocytes and / or embryos. DETAILED DESCRIPTION

[0020] The invention provides an oocyte and embryo vitrification freezing carrier, comprising a freezing tube body, one end of which is a U-shaped bevel, and is characterized in that a water-absorbing material is attached to the inner wall of the U-shaped bevel end of the freezing tube body.

[0021] The oocyte and embryo vitrification carrier of the present invention is suitable for humans and animals.

[0022] In the present invention, the water-absorbing material preferably includes filter paper, which is economical and cheap. The oocyte and embryo vitrification freezing carrier of the present invention can achieve a freezing effect comparable to that of Cryotop, but is more economical and has a lower cost. The price of Cryotop is US$20, while the embryo vitrification freezing carrier of the present invention costs about US$0.5. In the present invention, the shape of the water-absorbing material preferably includes a rectangle; the length of the water-absorbing material is preferably 18 to 20 mm, and the width of the water-absorbing material is preferably 5 to 6 mm. In the present invention, the outer edge of the water-absorbing material is flush with the outer edge of the U-shaped bevel.

[0023] In the present invention, the angle of the U-shaped bevel is preferably 60°; the length of the U-shaped bevel is 0.5 to 1 cm.

[0024] In the present invention, the method for preparing the oocyte and embryo vitrified cryocarrier preferably comprises the following steps: beveling one end of a semen cryotube to form a cryotube body having a U-shaped bevel; and attaching a water absorbing material to the inner wall of the U-shaped bevel end of the cryotube body.

[0025] In the present invention, the bevel cutting is preferably performed with a scalpel; the specification of the bevel cutting semen cryotube is preferably 0.25mL or 0.5mL, and the structural schematic diagram of the semen cryotube is shown in Figure 1, see the schematic diagram of the oblique cut Figure 2 .

[0026] In the present invention, the water-absorbing material is inserted into the freezing tube body from the U-shaped oblique opening, and naturally adheres to the inner wall of the freezing tube body without being adhered by an adhesive. Figure 3 .

[0027] The present invention also provides a method for vitrification of oocytes and / or embryos based on the oocyte and embryo vitrification carrier described in the above scheme, comprising the following steps:

[0028] The cryoprotectant containing oocytes and / or embryos is transferred to the absorbent material of the vitrified cryoprotectant described in the above scheme, and its front end is directly immersed in liquid nitrogen for freezing. The cryoprotectant is then placed in a common liquid nitrogen tank for storage. See the schematic diagram for Figure 4 .

[0029] The oocyte and embryo vitrified cryocarriers of the present invention are preferably sterilized before use; the sterilization method is preferably gas sterilization, more preferably ozone sterilization.

[0030] In the present invention, the transfer time is preferably 5 to 10 seconds before the oocytes and embryos are frozen by the freezing solution.

[0031] The present invention has no special restrictions on the formula of the freezing liquid, and conventional vitrification freezing liquid and freezing method in the art can be used.

[0032] After vitrification of the oocytes and embryos, the present invention preferably further comprises thawing; the thawing method comprises: adding the vitrified freezing carrier into a thawing solution for thawing. The present invention has no special restrictions on the formula of the thawing solution and the thawing parameters, and the vitrification thawing solution commonly used in the art can be used.

[0033] The technical solution of the present invention will be clearly and completely described below in conjunction with the embodiments of the present invention.

[0034] Example 1

[0035] 1) Use a scalpel to cut off the top of a 0.25 ml sperm cryotube at an angle of 60 degrees, 1.0 cm from the front end, so that a U-groove bevel is formed at the bottom of the tube;

[0036] 2) Insert a 20 mm long and 5 mm wide chemical filter paper into the U-groove oblique capillary tube, and make the front end of the filter paper flush with the front end of the capillary tube; put 10 to 15 paper tubes into a gas sterilization bag and perform gas sterilization to obtain a sterilized vitrified cryotransfer carrier (paper tube);

[0037] 3) 5 to 10 seconds before the freezing treatment of the oocytes and embryos is completed, the freezing solution containing the oocytes and / or embryos is transferred to the absorbent material of the paper tube obtained in step 2) and moved into liquid nitrogen for freezing.

[0038] Place the paper tube directly into the thawing solution to thaw.

[0039] Example 2

[0040] 1. Oocyte acquisition

[0041] 8-10 week old female mice (F1 female mice obtained by crossbreeding Swiss mice and B6D2) were intraperitoneally injected with 10 IU / mouse PMSG (Sigma), and 48-50 hours later, 100 IU / mouse HCG was injected. The mice were killed by cervical dislocation 18-20 hours after the injection of HCG (Sigma), and the oviducts were removed and placed in the culture medium M2 (Sigma). Under a dissecting microscope, the enlarged part of the oviduct was cut open with a syringe needle, and the cumulus-ovum complex was visible. The oviduct was transferred into a hyaluronidase solution (Sigma) containing 80 IU / ml for digestion, and the oocytes with normal morphology and the first polar body were collected and placed in M16 (Sigma) solution. After being covered, they were placed in a 37°C 5% incubator for use.

[0042] 2. Embryo acquisition

[0043] Using the above mouse superovulation scheme, 8-10 week old female mice (F1 female mice obtained by crossbreeding Swiss mice and B6D2) were injected with PMSG and HCG intraperitoneally for superovulation treatment, and then caged with male mice at a ratio of 1:1. On the 3rd to 3.5th day after caged plugging, the donor mice were killed by cervical dislocation, disinfected by alcohol soaking, and the abdominal skin was cut open in the dissection dish and expanded upward to expose the abdominal wall muscles. Then the muscles were cut open at the front edge of the pubic bone, and the internal organs were opened to expose the uterine horns. The fat on the uterine horns was first peeled off with ophthalmic scissors. After cutting at the cervix, the uterine horns were taken out together with the fallopian tubes and ovaries and placed in a 50mm watch dish. First, a No. 5 fine needle was used to pick open the junction of the uterine horns and the fallopian tubes, and then 1-2 mL of DPBS (Sigma) + 5% BSA solution (37°C) was drawn with a syringe, and a special flat-head injection needle was connected to enter the uterine horns on both sides from the uterine body to flush the embryos. After flushing out the liquid and letting it stand for a while, under a stereo microscope, use an egg picking needle to pick out well-developed blastocyst-stage embryos, put them into M16 solution, and place them in a 37°C 5% incubator for later use.

[0044] 3. Vitrification Procedure

[0045] The freezing basal solution (Holding Solution, HS) contains calf blood (Fetal Calf Serum, FCS) 10% (v / v) + DPBS (Sigma). First, the oocytes or embryos were pre-equilibrated in the basal solution for 2 minutes at room temperature, and then moved into the equilibrium solution (Equilibrium Solution, ES), which contains dimethyl sulfoxide (Dimethy sulfoxid, DMSO) 7.5% (V / V) + ethylene glycol (Ethylene Glycol, EG) 7.5% (V / V) for 3 minutes; finally, they were balanced in the vitrification solution (Vitrification Solution, VS): DMSO 15% (V / V) + EG 15% (V / V) + 1.0M sucrose for 90s (oocytes) or 45 (embryos). According to the experimental requirements, the oocytes or embryos were loaded into different vitrification carriers (OPS, Cryotop and paper tubes) and directly put into liquid nitrogen for freezing.

[0046] 4. Thawing procedure

[0047] Before thawing oocytes or embryos, warm the thawing solution to room temperature, remove the frozen carrier from liquid nitrogen, expose it to air for 3 seconds, and then place the front end in thawing solution 1 (basal solution + 1.0M sucrose) to allow the oocytes or embryos to fall into the liquid. After balancing for 1 minute, transfer to thawing solution 2 (basal solution + 0.5M sucrose), thawing solution 3 (basal solution + 0.25M sucrose), and each in the basic solution for 3 minutes. The thawed oocytes were fertilized in vitro, and the fertilization rate and blastocyst development rate were observed; the thawed embryos will continue to be cultured to observe their survival rate, development rate and hatching rate.

[0048] 5. In vitro fertilization (IVF) and development of oocytes

[0049] The thawed oocytes were transferred to fertilization fluid (HTF, Sigma) and cultured at 37°C, 5% CO2 for 2 hours before fertilization. During this period, male mice aged 10 to 14 weeks were killed by cervical dislocation, and the abdomen was cut open to expose the testicles and epididymis of the male mice. The epididymis was separated, punctured / cut, and the semen was taken out and placed in TYH (Sigma) culture drops. The culture drops were placed in a 37°C, 5% CO2 incubator to incubate the sperm for 1 to 2 hours. The motility and state of the sperm were observed under an optical microscope. According to the state of the sperm, an appropriate amount of sperm was dropped into the culture drops of the incubated oocytes for in vitro fertilization (fertilization density was 2×10 5Sperm / ml). About 4 hours after fertilization, the culture medium was changed, and the embryos were washed 3 times with M2, then transferred to M6 culture medium and continued to be cultured in a CO2 incubator. The recovery rate and cleavage rate were calculated 16 to 24 hours after fertilization, and the blastocyst rate was calculated on the 5th day after fertilization. The hatching rate was calculated on the 6th day after fertilization.

[0050] Recovery rate = number of surviving oocytes / number of thawed oocytes × 100%;

[0051] Cleavage rate = number of fertilized eggs / total number of eggs × 100%.

[0052] Blastocyst rate = number of blastocysts / total oocytes × 100%.

[0053] Hatching rate = number of hatched blastocysts / total number of blastocysts × 100%.

[0054] 6. Embryonic development

[0055] The thawed blastocysts were placed in M16 solution and placed in a 37°C 5% incubator for 48 hours for observation. The recovery rate and blastocyst rate were recorded and counted at 24 hours. The blastocyst hatching rate was recorded and counted at 48 hours.

[0056] Recovery rate = number of surviving blastocysts / number of thawed blastocysts × 100%;

[0057] Blastocyst rate = number of blastocysts / total number of thawed embryos × 100%;

[0058] Blastocyst hatching rate = number of hatched blastocysts / total number of blastocysts × 100%.

[0059] Experimental Design and Results

[0060] 1. Biostatistical methods

[0061] SPSS 11.5 software was used for statistical analysis, and the chi-square test was used for count data. The threshold for significant difference was set at P < 0.05. Different letters represent significant differences.

[0062] 2. Oocyte vitrification

[0063] Table 1 Effects of different vitrification carriers on oocyte freezing, in vitro fertilization and embryo development

[0064]

[0065] 3. Embryo Vitrification

[0066] Table 2 Effects of different vitrification carriers on cryopreservation and embryo development

[0067] Experimental Group Number of blastocysts Recovery rate (%) Blastocyst rate (%) Blastocyst hatching rate (%) Fresh blastocyst 65 <![CDATA[58(89%) a ]]> <![CDATA[39(67%) a ]]> OPS 76 <![CDATA[64(84%) a ]]> <![CDATA[57(75%) b ]]> <![CDATA[24(42%) b ]]> Cryotop 80 <![CDATA[68(85%) a ]]> <![CDATA[63(79%) b ]]> <![CDATA[32(51%) c ]]> Paper Tube 89 <![CDATA[79(89%) a ]]> <![CDATA[72(81%) ab ]]> <![CDATA[40(56%) c ]]>

[0068] Although the above embodiment describes the present invention in detail, it is only a part of the embodiments of the present invention rather than all the embodiments. People can also obtain other embodiments based on this embodiment without creativity, and these embodiments all fall within the protection scope of the present invention.

Claims

1. An oocyte and embryo vitrification freezing carrier, consisting of a cryotube body, one end of which is a U-shaped bevel. It is characterized in that A water-absorbing material is attached to the inner wall of the U-shaped oblique end of the freezing tube body; The angle of the U-shaped bevel is 60°; The length of the U-shaped bevel is 0.5 to 1 cm; The water absorbing material comprises filter paper.

2. The oocyte and embryo vitrification carrier according to claim 1, It is characterized in that The shape of the water-absorbing material includes a rectangle; the length of the water-absorbing material is 18 to 20 mm, and the width of the water-absorbing material is 5 to 6 mm.

3. The oocyte and embryo vitrification carrier according to claim 2, It is characterized in that The outer edge of the water absorbing material is flush with the outer edge of the U-shaped bevel.

4. The oocyte and embryo vitrification carrier according to claim 1, It is characterized in that The freezing tube body is prepared by obliquely cutting one end of a semen freezing tube; the specification of the semen freezing tube is 0.25 mL.

5. A method for vitrification of oocytes and / or embryos based on the oocyte and embryo vitrification carrier according to any one of claims 1 to 4, The following steps are involved: The freezing liquid containing oocytes and / or embryos is transferred to the water-absorbing material of the oocyte and embryo vitrification freezing carrier according to any one of claims 1 to 4, and is frozen with liquid nitrogen.

6. The vitrification method according to claim 5, It is characterized in that The transfer starts 5 to 10 seconds before the embryos are frozen by the freezing solution.